• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全转录组测序揭示韩国胃肠道癌症患者癌症微生物组特征:作为一种治疗靶点

Whole-Transcriptome Sequencing Reveals Characteristics of Cancer Microbiome in Korean Patients with GI Tract Cancer: as a Therapeutic Target.

作者信息

Ahn Hyeok, Min Kyungchan, Lee Eulgi, Kim Hyun, Kim Sujeong, Kim Yunjae, Kim Gihyeon, Cho Beomki, Jeong Chanyeong, Kim Yeongmin, Park Hansoo

机构信息

Department of Biomedical Science and Engineering, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.

出版信息

Microorganisms. 2022 Sep 23;10(10):1896. doi: 10.3390/microorganisms10101896.

DOI:10.3390/microorganisms10101896
PMID:36296174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9610011/
Abstract

Remarkable progress has occurred over the past two decades in identifying microbiomes affecting the human body in numerous ways. The microbiome is linked to gastrointestinal (GI) tract cancer. The purpose of this study was to determine if there is a common microbiome among GI tract cancers and how the microbiome affects the disease. To ensure ethnic consistency, Korean patients with GI tract cancer were selected. is an enriched bacteria in all cancer tissues. is a Gram-negative obligate anaerobe that promotes colorectal cancer. Through Gene Set Enrichment Analysis (GSEA) and Differentially Expressed Genes (DEG) analyses, the upregulation of the G2M checkpoint pathway was identified in the -high group. Cell viability and G2M checkpoint pathway genes were examined in MC 38 cells treated with . upregulated the expression of G2M checkpoint pathway genes and the cell proliferation of MC 38 cells. facilitated cancer's use of G2M checkpoint pathways and could be a therapeutic target in Korean GI tract cancer.

摘要

在过去二十年里,在识别以多种方式影响人体的微生物群方面取得了显著进展。微生物群与胃肠道(GI)癌症有关。本研究的目的是确定胃肠道癌症之间是否存在共同的微生物群,以及微生物群如何影响该疾病。为确保种族一致性,选择了韩国胃肠道癌症患者。 是所有癌症组织中富集的细菌。 是一种促进结直肠癌的革兰氏阴性专性厌氧菌。通过基因集富集分析(GSEA)和差异表达基因(DEG)分析,在 -高组中发现了G2M检查点通路的上调。在用 处理的MC 38细胞中检测了细胞活力和G2M检查点通路基因。 上调了G2M检查点通路基因的表达和MC 38细胞的细胞增殖。 促进了癌症对G2M检查点通路的利用,并且 可能是韩国胃肠道癌症的一个治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09cf/9610011/abdf7a039e9a/microorganisms-10-01896-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09cf/9610011/c36fd690a317/microorganisms-10-01896-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09cf/9610011/d0fa8f1590da/microorganisms-10-01896-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09cf/9610011/5d5dd272c024/microorganisms-10-01896-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09cf/9610011/abdf7a039e9a/microorganisms-10-01896-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09cf/9610011/c36fd690a317/microorganisms-10-01896-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09cf/9610011/d0fa8f1590da/microorganisms-10-01896-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09cf/9610011/5d5dd272c024/microorganisms-10-01896-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09cf/9610011/abdf7a039e9a/microorganisms-10-01896-g004.jpg

相似文献

1
Whole-Transcriptome Sequencing Reveals Characteristics of Cancer Microbiome in Korean Patients with GI Tract Cancer: as a Therapeutic Target.全转录组测序揭示韩国胃肠道癌症患者癌症微生物组特征:作为一种治疗靶点
Microorganisms. 2022 Sep 23;10(10):1896. doi: 10.3390/microorganisms10101896.
2
Analysis of 16S rRNA genes reveals reduced Fusobacterial community diversity when translocating from saliva to GI sites.16S rRNA 基因分析显示,从唾液转移到胃肠道部位时,梭杆菌门的群落多样性减少。
Gut Microbes. 2020 Nov 9;12(1):1-13. doi: 10.1080/19490976.2020.1814120.
3
Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.机会性检测具核梭杆菌作为早期肠道微生物失调的标志物。
BMC Microbiol. 2020 Jul 13;20(1):208. doi: 10.1186/s12866-020-01887-4.
4
and colorectal cancer: A review.以及结直肠癌:一篇综述。
World J Gastrointest Oncol. 2018 Mar 15;10(3):71-81. doi: 10.4251/wjgo.v10.i3.71.
5
Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.具核梭杆菌通过改变小鼠模型的黏膜微生物群和结肠转录组促进结直肠癌的进展。
World J Gastroenterol. 2022 May 14;28(18):1981-1995. doi: 10.3748/wjg.v28.i18.1981.
6
Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.具核梭杆菌与结直肠癌免疫及分子改变的关联
World J Gastroenterol. 2016 Jan 14;22(2):557-66. doi: 10.3748/wjg.v22.i2.557.
7
Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.具核梭杆菌通过激活Toll样受体4信号传导至核因子κB并上调微小RNA-21的表达来增加结肠直肠癌细胞的增殖和小鼠肿瘤的发展。
Gastroenterology. 2017 Mar;152(4):851-866.e24. doi: 10.1053/j.gastro.2016.11.018. Epub 2016 Nov 19.
8
Impact of in the gastrointestinal tract on natural killer cells.在胃肠道中对自然杀伤细胞的影响。
World J Gastroenterol. 2021 Aug 7;27(29):4879-4889. doi: 10.3748/wjg.v27.i29.4879.
9
Target identification in Fusobacterium nucleatum by subtractive genomics approach and enrichment analysis of host-pathogen protein-protein interactions.通过消减基因组学方法和宿主-病原体蛋白质-蛋白质相互作用的富集分析鉴定具核梭杆菌中的靶点
BMC Microbiol. 2016 May 12;16:84. doi: 10.1186/s12866-016-0700-0.
10
Application of as a biomarker in gastrointestinal malignancies.作为生物标志物在胃肠道恶性肿瘤中的应用。
World J Gastrointest Oncol. 2024 Jun 15;16(6):2271-2283. doi: 10.4251/wjgo.v16.i6.2271.

引用本文的文献

1
Comparative microbiome analysis of paired mucosal and fecal samples in Korean colorectal cancer patients.韩国结直肠癌患者配对黏膜和粪便样本的微生物组比较分析。
Front Oncol. 2025 Jun 18;15:1578861. doi: 10.3389/fonc.2025.1578861. eCollection 2025.
2
Intratumor microbiota and colorectal cancer: Comprehensive and lucid review.肿瘤内微生物群与结直肠癌:全面而清晰的综述。
Chin J Cancer Res. 2024 Dec 30;36(6):683-699. doi: 10.21147/j.issn.1000-9604.2024.06.07.
3
: An Overview of Evidence, Demi-Decadal Trends, and Its Role in Adverse Pregnancy Outcomes and Various Gynecological Diseases, including Cancers.

本文引用的文献

1
Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response.具核梭杆菌:癌症发展调控及治疗反应中的新角色
Cancer Drug Resist. 2022 May 12;5(2):436-450. doi: 10.20517/cdr.2021.144. eCollection 2022.
2
Oral Species and Their Connection to Events of Clinical Relevance in Gastrointestinal and Respiratory Tracts.口腔物种及其与胃肠道和呼吸道临床相关事件的联系。
Front Microbiol. 2022 Jan 6;12:798763. doi: 10.3389/fmicb.2021.798763. eCollection 2021.
3
The microbiome, gastrointestinal cancer, and immunotherapy.
证据概述、十年半趋势及其在不良妊娠结局和各种妇科疾病(包括癌症)中的作用。
Cells. 2024 Apr 20;13(8):717. doi: 10.3390/cells13080717.
4
Statistical normalization methods in microbiome data with application to microbiome cancer research.微生物组数据的统计归一化方法及其在微生物组癌症研究中的应用。
Gut Microbes. 2023 Dec;15(2):2244139. doi: 10.1080/19490976.2023.2244139.
5
Therapeutic Target Identification and Inhibitor Screening against Riboflavin Synthase of Colorectal Cancer Associated .针对结直肠癌相关核黄素合酶的治疗靶点鉴定与抑制剂筛选
Cancers (Basel). 2022 Dec 19;14(24):6260. doi: 10.3390/cancers14246260.
微生物组、胃肠道癌症和免疫疗法。
J Gastroenterol Hepatol. 2022 Feb;37(2):263-272. doi: 10.1111/jgh.15742. Epub 2021 Dec 3.
4
Microbiome and cancer.微生物群与癌症
Cancer Cell. 2021 Oct 11;39(10):1317-1341. doi: 10.1016/j.ccell.2021.08.006. Epub 2021 Sep 9.
5
RNA sequencing: new technologies and applications in cancer research.RNA 测序:癌症研究中的新技术和应用。
J Hematol Oncol. 2020 Dec 4;13(1):166. doi: 10.1186/s13045-020-01005-x.
6
The Oral Microbiome and Cancer.口腔微生物群与癌症
Front Immunol. 2020 Oct 23;11:591088. doi: 10.3389/fimmu.2020.591088. eCollection 2020.
7
Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients.具核梭杆菌与 Lauren 弥漫型胃癌患者的预后不良相关。
Sci Rep. 2020 Oct 1;10(1):16240. doi: 10.1038/s41598-020-73448-8.
8
Microbiome as a Target for Cancer Therapy.微生物组作为癌症治疗的靶点。
Integr Cancer Ther. 2020 Jan-Dec;19:1534735420920721. doi: 10.1177/1534735420920721.
9
The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response.肠道微生物群在结直肠癌发生发展及治疗反应中的作用
Cancers (Basel). 2020 May 29;12(6):1406. doi: 10.3390/cancers12061406.
10
Improved metagenomic analysis with Kraken 2.Kraken 2 提升宏基因组分析。
Genome Biol. 2019 Nov 28;20(1):257. doi: 10.1186/s13059-019-1891-0.